The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?

Learning and Memory

Volumn 11, Issue 1, 2004, Pages 43-49

  Mesulam, Marsel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; BEHAVIOR DISORDER; BRAIN CORTEX; CHOLINERGIC NERVE; COGNITIVE DEFECT; DISEASE COURSE; HUMAN; NERVE CELL PLASTICITY; NERVE LESION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SYMPTOMATOLOGY;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; ATTENTION; BRAIN; CHOLINERGIC FIBERS; DISEASE PROGRESSION; HUMANS; MEMORY; NEUROFIBRILLARY TANGLES; NEURONAL PLASTICITY; PHOSPHORYLATION; SENILE PLAQUES;

EID: 0842304284     PISSN: 10720502     EISSN: None     Source Type: Journal    
DOI: 10.1101/lm.69204     Document Type: Review

References (87)

1. Arendash, G.W., Millard, W.J., Dunn, A.J., and Meyer, E.M. 1987. Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science 238: 952-956.
2. Auerbach, J.M. and Segal, M. 1994. A novel cholinergic induction of long-term potentiation in rat hippocampus. J. Neurophysiol. 72: 2034-2040.
3. Auld, D.S., Kar, S., and Quirion, R. 1998. β-Amyloid peptides as direct cholinergic neuromodulators: A missing link? Trends Neurosci. 21: 43-49.
4. Bartus, R.T., Dean, R.L., Beer, B., and Lippa, A.D. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417.
5. Baskerville, K.A., Schweitzer, J.B., and Herron, P. 1997. Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat. Neuroscience 80: 1159-1169.
6. Baskin, D.S., Browning, J.L., Pirozzolo, F.J., Korporaal, S., Baskin, J.A., and Appel, S.A. 1999. Brain choline acetyltransferase and mental function in Alzheimer disease. Arch. Neurol. 56: 1121-1123.
7. Bear, M.F. and Singer, W. 1986. Modulation of visual cortical plasticity by acetylcholine and noradrenaline. Nature 320: 172-176.
8. Berger-Sweeney, J., Heckers, S., Mesulam, M.M., Wiley, R.G., Lappi, D.A., and Sharma, M. 1994. Differential effects upon spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J. Neurosci. 14: 4507-4519.
9. Bowen, D.M., Smith, C.B., White, P., and Davison, A.N. 1976. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459-496.
10. Bowen, D.M., Benton, J.S., Spillane, J.A., Smith, C.C.T., and Allen, S.J. 1982. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J. Neurol. Sci. 57: 191-202.
11. Buszáki, G. 1989. Commentary: Two-stage model of memory trace formation: A role for "noisy" brain states. Neuroscience 31: 551-570.
12. Conner, J.M., Culberson, A., Packowski, C., Chiba, A.A., and Tuszynski, M.H. 2003. Lesions of the basal forebrain cholinergic system impair task acquisition and abolish cortical plasticity associated with motor skill learning. Neuron 38: 819-829.
13. Coyle, J.T., Price, D.L., and DeLong, M.R. 1983. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 219: 1184-1190.
14. Daffner, K.R., Scinto, L.F., Weintraub, S., Guinessey, J.E., and Mesulam, M.M. 1992. Diminished curiosity in patients with probable Alzheimer's disease as measured by exploratory eye movements. Neurology 42: 320-328.
15. Davies, P. and Maloney, A.J.F. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1943.
16. Davis, K.L., Mohs, R.C., Marin, D., Purohit, D.P., Perl, D.P., Lantz, M., Austin, G., and Haroutunian, V. 1999. Cholinergic markers in elderly patients with early signs of Alzheimer's disease. J. Am. Med. Assoc. 281: 1401-1406.
17. DeKosky, S.T., Ikonomovic, M.D., Styren, S.D., Beckett, L., Wisniewski, S., Bennett, D.A., Cochran, E.J., Kordower, J.H., and Mufson, E.J. 2002. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 51: 145-155.
18. DeLong, M.R. 1971. Activity of pallidal neurons during movement. J. Neurophysiol. 34: 414-427.
19. Dias, E.C., Compaan, D.M., Mesulam, M.M., and Segraves, M.A. 1996. Selective disruption of memory-guided saccades with injecton of a cholinergic antagonist in the frontal eye field of monkey. Soc. Neurosci. Abst. 22: 418.
20. Doody, R.S., Stevens, J.C., Beck, C., Dubinsky, R.M., Kaye, J.A., Gwyther, L., Mohs, R.C., Thal, L.J., Whitehouse, P.J., DeKosky, S.T., et al. 2001. Practice parameter: Management of dementia (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 56: 1154-1166.
21. Drachman, D.A. and Leavitt, J. 1974. Human memory and the cholinergic system-A relationship to aging? Arch. Neurol. 30: 113-121.
22. Dringenberg, H.C. and Vanderwolf, C.H. 1996. Cholinergic activation of the electrocorticogram: An amygdaloid activating system. Exper. Brain Res. 108: 285-296.
23. Efange, S.M.N., Garland, E.M., Staley, J.K., Khare, A.B., and Mash, D.C. 1997. Vesicular acetylcholine transporter density and Alzheimer's disease. Neurobiol. Aging 18: 407-413.
24. Emre, M., Heckers, S., Mash, D.C., Geula, C., and Mesulam, M.M. 1993. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease. J. Comp. Neurol. 336: 117-134.
25. Everitt, B.J. and Robbins, T.W. 1997. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48: 649-684.
26. Francis, P.T., Palmer, A.M., Sims, N.R., Bowen, D.M., Davison, A.N., Esiri, M.M., Neary, D., Snowden, J.S., and Wilcock, G.K. 1985. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. New Eng. J. Med. 313: 7-11.
27. Galani, R., Lehmann, O., Bolmont, T., Aloy, E., Bertrand, F., Lazarus, C., Jeltsch, H., and Cassel, J.C. 2002. Selective immunolesions of CH4 cholinergic neurons do not disrupt spatial memory in rats. Physiol. Behav. 76: 75-90.
28. Geula, C. and Mesulam, M.M. 1989. Cortical cholinergic fibers in aging and Alzheimer's disease: A morphometric study. Neuroscience 33: 469-481.
29. -. 1996. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cerebral Cortex 6: 165-177.
30. -. 1999. Cholinergic systems in Alzheimer's disease. In Alzheimer disease, 2nd Ed. (eds. R.D. Terry et al.), pp. 69-292. Lippincott, Williams & Wilkins, Philadelphia, PA.
31. Gilmor, M.L., Erickson, J.D., Varoqui, H., Hersh, L.B., Bennett, D.A., Cochran, E.J., Mufson, E.J., and Levey, A.I. 1999. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 411: 693-704.
32. Hammond, E.J., Meador, K.J., Aunq-Din, R., and Wilder, B.J. 1987. Cholinergic modulation of human P3 event-related potentials. Neurology 37: 346-350.
33. Hasselmo, M.E. 1992. Cholinergic modulation of cortical associative memory function. J. Neurophysiol. 67: 1230-1246.
34. Himmelheber, A.M., Sarter, M., and Bruno, J.P. 2001. The effects of manipulations of attentional demand on cortical acetylcholine release. Cog. Brain Res. 12: 353-370.
35. Hyman, B.T. and Trojanowski, J.Q. 1997. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer's disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. J. Neuropathol. Exper. Neurol. 56: 1095-1097.
36. Katzman, R. 1976. The prevalence and malignancy of Alzheimer disease. Arch. Neurol. 33: 217-218.
37. Kelly, J.F., Furukawa, K., Barger, S.W., Rengen, M.R., Mark, R.J., Blanc, E.M., Roth, G.S., and Mattson, M.P. 1996. Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. 93: 6753-6758.
38. Kihara, T., Shimohama, S., Sawaa, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., and Akaike, A. 1997. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann. Neurol. 42: 159-163.
39. Kilgard, M.P. and Merzenich, M.M. 1998. Cortical map reorganization enabled by nucleus basalis activity. Science 279: 1714-1718.
40. Kraepelin, E. 1910. Lehrbuch der Psychiatrie. Leipzig, Barth.
41. Kuhl, D.E., Minoshima, S., Fessler, J.A., Frey, K.A., Foster, N.L., Ficaro, E.P., Wieland, D.M., and Koeppe, R.A. 1996. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann. Neurol. 40: 399-410.
42. Levey, A.I., Wainer, B.H., Rye, D.B., Mufson, E.J., and Mesulam, M.M. 1984. Choline acetyltransferase-immunoreactive neurons intrinsic to rodent cortex and distinction from acetylcholinesterase-positive neurons. Neuroscience 13: 341-353.
43. London, E.D., Ball, M.J., and Waller, S.B. 1989. Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia. Neurochem. Res. 14: 745-750.
44. Mash, D.C., Flynn, D.D., and Potter, L.T. 1985. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228: 115-117.
45. Mash, D.C., White, W.F., and Mesulam, M.M. 1988. Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex. J. Comp. Neurol. 278: 265-274.
46. McCormick, D.A. 1990. Cellular mechanisms of cholinergic control of neocortical and thalamic neuronal excitability. In Brain cholinergic systems (eds. M. Steriade and D. Biesold), pp. 236-264. Oxford University Press, Oxford, UK.
47. McGaugh, J.L., Introini-Collison, I.B., Cahill, L.F., Castellano, C., Dalmaz, C., Parent, M.B., and Williams, C.L. 1993. Neuromodulatory systems and memory storage: Role of the amygdala. Behav. Brain Res. 58: 81-90.
48. McKhann, G., Drachman, D.A., Folstein, M., Katzman, R., Price, D., and Stadlan, E.M. 1984. Clinical diagnosis of Alzheimer's disease. Neurology 34: 939-944.
49. Mesulam, M.M. 1999. Neuroplasticity failure in Alzheimer's disease: Bridging the gap between plaques and tangles. Neuron 24: 521-529.
50. -. 2000a. Aging, Alzheimer's disease, and dementia: Clinical and neurobiological perspectives. In Principles of behavioral and cognitive neurology (ed. M.M. Mesulam), pp. 439-522. Oxford University Press, New York.
51. -. 2000b. Behavioral neuroanatomy: Large-scale networks, association cortex, frontal syndromes, the limbic system and hemispheric specialization. I Principles of behavioral and cognitive neurology (ed. M.M. Mesulam), pp. 1-120. Oxford University Press, New York.
52. -. 2004. The cholinergic innervation of the human cerebral cortex. Prog. Brain Res. (in press).
53. Mesulam, M.M. and Geula, C. 1988. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J. Comp. Neurol. 275: 216-240.
54. -. 1993. Chemoarchitectonics of axonal and perikaryal acetylcholinesterase along information processing systems of the human cerebral cortex. Brain Res. Bull. 33: 137-153.
55. Mesulam, M.M. and Mufson, E.J. 1984. Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey. Brain 107: 253-274.
56. Mesulam, M.M. and Van Hoesen, G.W. 1976. Acetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex. Brain Res. 109: 152-157.
57. Mesulam, M.M., Mufson, E.J., Levey, A.I., and Wainer, B.H. 1983a. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214: 170-197.
58. Mesulam, M.M., Mufson, E.J., Wainer, B.H., and Levey, A.I. 1983b. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10: 1185-1201.
59. Mesulam, M.M., Mufson, E.J., and Rogers, J. 1987. Age-related shrinkage of cortically projecting cholinergic neurons: A selective effect. Ann. Neurol. 22: 31-36.
60. Mesulam, M.M., Hersh, L.B., Mash, D.C., and Geula, C. 1992. Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: A choline acetyltransferase study. J. Comp. Neurol. 318: 316-328.
61. Mesulam, M.M., Guillozet, A., Shaw, P., Levey, A., Duysen, E.G., and Lockridge, O. 2002. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110: 627-639.
62. Metherate, R., Cox, C.L. and Ashe, J.H. 1992. Cellular bases of neocortical activation: Modulation of neuronal oscillations by the nucleus basalis and endogenous acetylcholine. J. Neurosci. 12: 4701-4711.
63. Minger, S.L., Esiri, M.M., McDonald, B., Keene, J., Carter, J., Hope, T., and Francis, P.T. 2000. Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology 55: 1460-1467.
64. Nitsch, R.M., Slack, B.E., Wurtman, R.J., and Growdon, J.H. 1992. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258: 304-307.
65. Pappas, B.A., Bayley, P.J., Bui, B.K., Hansen, L.A., and Thal, L. 2000. Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients. Neurobiol. Aging 21: 11-17.
66. Perry, E.K., Blessed, G., Tomlinson, B.E., Perry, R.H., Crow, T.J., Cross, A.J., Dockray, G.J., Dimaline, R., and Arregui, A. 1981. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol. Aging 2: 251-256.
67. Perry, E.K., Kilford, L., Lees, A.J., Burn, D.J., and Perry, R.H. 2003. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann. Neurol. 54: 235-238.
68. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos, E.G., and Kokmen, E. 1999. Mild cognitive impairment. Clinical characterization and outcome. Arch. Neurol. 56: 303-308.
69. Power, A.E., Thal, L.J., and McGaugh, J.L. 2002. Lesions of the nucleus basalis magnocellularis induced by 192 IgG-saporin block memory enhancement with posttraining norepinephrine in the basolateral amygdala. Proc. Natl. Acad. Sci. 99: 2315-2319.
70. Price, B.H., Gurvit, H., Weintraub, S., Geula, C., Leimkuhler, E., and Mesulam, M. 1993. Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease. Arch. Neurol. 50: 931-937.
71. Ramon-Moliner, E. and Nauta, W.J.H. 1966. The isodendritic core of the brain. J. Comp. Neurol. 126: 311-336.
72. Ridley, R.M., Murray, T.K., Johnson, J.A., and Baker, H.F. 1986. Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: Modification by cholinergic drugs. Brain Res. 376: 108-116.
73. Sadot, E., Gurwitz, D., Barg, J., Behar, L., Ginzburg, I., and Fisher, A. 1996. Activation of ml muscarinic acetylcholine receptor regulates hyperphosphorylation in transfected PC12 cells. J. Neurochem. 66: 877-880.
74. Sarter, M. and Bruno, J.P. 2000. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 95: 933-952.
75. Sassin, I., Schultz, C., Thal, D.R., Rüb, U., Arai, K., Braak, E., and Braak, H. 2000. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathologica 100: 259-269.
76. Smiley, J.F. and Mesulam, M.M. 1999. Cholinergic neurons of the nucleus basalis of Meynert (Ch4) receive cholinergic, catecholaminergic, and GABAergic synapses: An electron microscopic investigation in the monkey. Neuroscience 88: 241-255.
77. Smiley, J.F., Morrell, F., and Mesulam, M.M. 1997. Cholinergic synapses in human cerebral cortex: An ultrastructural study in serial sections. Exper. Neurol. 144: 361-368.
78. Summers, W.K., Majorski, L.V., Marsh, G.M., Tachiki, K., and Kling, A. 1986. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. New Eng. J. Med. 315: 1241-1245.
79. Tanaka, Y., Sakurai, M. and Hayashi, S. 1989. Effect of scopolamine and HP029, a cholinesterase inhibitor, on long-term potentiation in hippocampal slices of guinea pig. Neuroscience Letters 98: 179-183.
80. Thal, L.J., Mandel, R.J., Terry, R.D., Buzsáki, G., and Gage, F.H. 1990. Nucleus basalis lesions fail to induce senile plaques in the rat. Exp. Neurol. 108: 88-90.
81. Voytko, M.L., Olton, D.S., Richardson, R.T., Gorman, L.K., Tobin, J.R., and Price, D.L. 1994. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J. Neurosci. 14: 167-186.
82. Wenk, G.L., Stoehr, J.D., Quintana, G., Mobley, S., and Wiley, R.G. 1994. Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14, 5986-5995.
83. Whalen, P.J., Knapp, B.S., and Pascoe, J.P. 1994. Neuronal activity within the nucleus basalis and conditioned neocortical electroencephalographic activation. J. Neurosci. 14: 1623-1633.
84. Whitehouse, P.J., Price, D.L., Clark, A.W., Coyle, J.T., and DeLong, M.R. 1981. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10: 122-126.
85. Wilson, F.A.W. and Rolls, E.T. 1990. Neuronal responses related to novelty and familiarity of visual stimuli in the substantia innominata, diagonal band of Broca and periventricular region of the primate basal forebrain. Exper. Brain Res. 80: 104-120.
86. Zarow, C., Lyness, S.A., Mortimer, J.A., and Chui, H.C. 2003. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 60: 337-341.
87. Zhu, X.O. and Waite, P.M.E. 1998. Cholinergic depletion reduces plasticity of barrel field cortex. Cerebral Cortex 8: 63-72.